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Abstract 
During drug discovery and development, the routes of administration are normally cho-
sen for practical reasons. Commonly, the most desirable strategy is oral administration, 
since it is more convenient, painless, and allows easy self-administration. Therefore, 
oral bioavailability is one of the most important properties in drug discovery and devel-
opment. On one hand, a high oral bioavailability allows reducing the amount of an ad-
ministered drug necessary to achieve a desired pharmacological effect, and therefore 
reducing the risk of side-effects and toxicity. On the other hand, the low oral bioavaila-
bility in clinical trials is a major reason for drug candidates failing to reach the market.  
Because the absorption of an orally administered drug occurs mostly by passive dif-
fusion, membrane permeation is recognized as a common requirement for oral bioa-
vailability, and consequently, a number of eminent researchers, such as C. A. Lipinski 
and D. F. Veber, have defined rules that described the most relevant molecular proper-
ties required for a molecule to be bioavailable. 
In this work, it was pretended, using a computational approach, to understand the 
conceptual and theoretical framework of Lipinski and Veber’s rules, and to establish the 
molecular properties that are essential for the passive diffusion of compounds through 
cell membranes. 
For this purpose, we started by selecting a small library of compounds, and their 
free energies in water and in 1-octanol were calculated in order to validate the force 
field that was being used. Next, the passive diffusion process for caffeine, nelfinavir, 
and atorvastatin in a DOPC/water membrane model were simulated, and Gibbs energy 
profiles were obtained. Lastly, nelfinavir and atorvastatin’s rotatable bonds and PSA 
were characterized. During this stage the umbrella sampling protocol was carefully op-
timized, once it looks to be the most protocol suitable method for our studies. 
 
Key words: drug discovery, molecular dynamics, potential of mean force, free energy 
profile, umbrella sampling.   
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Resumo 
Durante a descoberta e desenvolvimento de um novo fármaco, a indústria farmacêuti-
ca dá preferência a uma formulação que possa ser administrada oralmente, uma vez 
que, para além de um fármaco administrado por via oral ser mais cómodo e indolor, 
permite uma autoadministração, o que aumenta a adesão à terapêutica.  
Porém, a biodisponibilidade de um fármaco oral é muito mais reduzida do que a de 
um fármaco administrado por outras vias, tal como por via intravenosa, visto que os 
fármacos orais necessitam de atravessar membranas biológicas. Quando não há 
transportadores, os fármacos orais atravessam as membranas por difusão passiva, e 
alguns autores, como Lipinski e Veber, definiram regras que descrevem as proprieda-
des moleculares necessárias para que uma molécula atravesse uma membrana bioló-
gica por difusão passiva. 
Através de uma abordagem computacional, pretendeu-se neste projeto: compreen-
der o fundamento molecular das regras de Lipinski e de Veber, e estabelecer, de for-
ma clara, as propriedades moleculares que são fundamentais para a permeação de 
membranas celulares por moléculas de pequena dimensão, através de difusão passi-
va. 
Para tal, numa primeira fase, foram estabelecidas as moléculas que serviram de 
base de estudo, bem como a parametrização e cálculo das suas energias livres de hi-
dratação e solvatação (em octanol) para validar o campo de forças. Numa segunda 
fase, simulou-se o processo de difusão passiva de cada três moléculas em estudo: 
cafeína, nelfinavir e atorvastatina, tendo-se obtido perfis de energia de Gibbs para a 
sua difusão através de um modelo de membrana celular. Finalmente, numa terceira 
fase, procedeu-se à caracterização de ligações rotáveis e de área superficial polar pa-
ra o nelfinavir e atorvastatina. 
 
Palavras-chave: descoberta de fármacos, dinâmica molecular, perfil de energia livre, 
umbrella sampling.   
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CHAPTER 1 
 
Introduction to Drug Discovery 
 
‘The process of drug discovery is not only of scientific interest, it 
entails a fascinating interplay among a variety of economic, social, 
and political institutions.’ [1] 
Donald Kennedy 
 
 
Discovery and developing a new drug is a long, costly, and risky process, 
which can take 12-20 years from the original idea to generate a marketed 
product. Working together medicinal chemists, pharmacologists, biochemists, 
molecular biologists, computer scientists, medical doctors, and even lawyers 
and economists make of drug research an interdisciplinary science. When a 
new drug is planned, its route of administration is chosen carefully. Overwhelm-
ingly, oral route is the most convenient; therefore, one of the most important 
goals for drug discovery and development is to understand the molecular prop-
erties that limit oral bioavailability. The pharmaceutical industry has been using 
computational methods to calculate those properties; however, such rules were 
based on simple and empirical observations, and they need to be understood if 
we want to refine and improve them. 
 
 
 
 
1.1   A brief history of drug discovery 
Drug research is not much older than a century, and it began in an era when chemistry 
had been capable of applying its principles and methods to problems outside chemistry 
itself, and when pharmacology had started to stand up as a scientific discipline. [2] In 
the beginning, organic chemists had the responsibility to create compounds, which 
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were designed individually and in large quantities, for being tested in live animals by 
pharmacologists. [3] 
The history of drug research was shaped and enriched not only by new technolo-
gies and new discoveries [2], but also by the ‘paradigm shift’ concept, which was intro-
duced by Thomas Kuhn in his book ‘The Structure of Scientific Revolutions’. Applying 
Thomas Kuhn’s concept to drug discovery means drug discovery was predominantly 
conducted by organic chemists in the beginning, but later, in the middle of the 20th cen-
tury, chemists, biologists, and pharmacologists have started to dialogue and work to-
gether; furthermore, biochemists and molecular biologists have also joined them in or-
der to help to bring drug discovery into a new level that had never been achieved be-
fore. [4] 
Biochemistry brought into drug discovery the knowledge of enzymes, receptors, 
and the basic skills required for monitoring routes of drug metabolism, pharmacokinetic 
analysis and safety testing, whereas molecular biology brought the knowledge that al-
lowed scientists to understand disease processes at the molecular and genetic levels, 
as well as to determine the optimum molecular targets for drug interference. [2] 
Moreover, computer science and bioinformatics also influenced drug research in 
many ways; most of the drugs discovered from the end of the 20th century have been 
developed with the help of computational methods. [5] 
In fact, drug discovery is no longer solely based on chemical synthesis, and is driv-
en instead by an interdisciplinary knowledge. 
 
1.2   The process of drug discovery 
When people buy medicines, they hardly imagine developing a new medicine is a 
complex, long, costly, and a high risky process. According to Pharmaceutical Research 
and Manufacturers of America, PhRMA, the research and development process of a 
new drug takes more than 10 years from the starting project to the approval from the 
FDA (US Food and Drug Administration). In addition, not only the average cost to de-
velop a new drug has been increasing over the years (with current costs approaching 
$2.6 billion, see Fig. 1), but also less than 12% of drug candidates (compounds with 
strong therapeutic potential, and whose activity and specificity have been optimized) 
will approved by the FDA. 
Drug discovery is a multi-step process; see Fig. 2, beginning with the identification 
of a medical need, when there are no satisfactory medicines for a disease or clinical 
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condition. Target identification and validation is one of the most important steps in the 
earlier phase of drug discovery; commonly, initial research starts in academia where 
the disease’s mechanisms are established allowing researchers to select specific tar-
gets. Such potential biological targets need to be efficacious and safe, and they are 
normally called ‘drugable targets’, which means the target needs to bind a drug mole-
cule with high affinity. [3, 6] 
Once the target has been identified, it needs to be validated in order to show its 
relevance as a target in a disease process. Target validation is performed by multiple 
approaches, and it is based on several criteria: different gene expression in healthy 
and diseased tissue, proteomic studies, and studies in animal models on the disease-
related phenotype. There are, nowadays, a range of techniques and methods available 
to perform these studies, which include: gene chips, neutralizing antibodies, knockout 
or transgenic mice, etc. [4, 6] 
The next step in drug discovery consists of exposing the target to a large number of 
molecular compounds in in vitro and in silico assays. When a biologically active com-
pound exceeds a certain activity threshold in a given assay it will be referred to as a 
HIT compound.  
A variety of compound screening assays exist, and the most used today is the au-
tomated high-throughput screening, HTS, which involves the screening of several mil-
lion molecules in an automatic manner. The use of HTS allows the pharmaceutical in-
dustry to reduce the time and the cost of HIT identification. [2, 3, 6]  
Fig. 1 - The increase in average cost to develop a new medicine (including the 
cost of failures) over the years. Adapted from phrma.org. 
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After HIT identification by HTS, those molecules are evaluated and undergo limited 
optimization strategies to find out the most promising compounds, lead compounds, to 
work with in more advanced stages of the drug discovery pipeline. Once a lead has 
been defined, it is important to understand precisely which structural features are re-
sponsible for its biological activity; typically, analog compounds are synthesized to ex-
plore structure-activity relationship (SAR) around each core compound structure, 
‘pharmacophore’, in an effort to maximize the desired activity. [3, 6, 7] 
However, the HIT compound’s pharmacokinetics must be validated through in vivo 
disease models, and this might be one of the most complex tasks to accomplish, be-
cause it mainly consist of evaluating several characteristics: absorption, distribution, 
metabolism, excretion, and toxicity. These characteristics are often abbreviated as 
ADMET. 
After the complete process of lead optimization, the molecule is declared as a pre-
clinical candidate, and the next phase will serve to determine whether a compound is 
suitable for human testing. If the compound fails the preclinical tests, researchers con-
Fig. 2 - This infographic provides a summary of the sequential steps that are necessary for a drug to progress 
through the research and development pipelines. Adapted from researchamerica.com. 
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tinue to synthesize and explore analogous compounds in order to produce back up 
molecules. [6] 
Finally, before the FDA approval, the candidate medicine undergoes the clinical tri-
als, a process that occurs in several phases: 
• Phase I (safety and dosage) - the new drug is tested in a small group of 
healthy volunteers to determine the safety and its metabolites in the body; 
• Phase II (efficacy and side effects) - the compound is tested in volunteer pa-
tients who have the diseases that are targeted by designed compound. In this 
phase the effectiveness and possible side effects are also determined; 
• Phase III (efficacy and monitoring of adverse effects) - the compound is 
tested in a large group comprising thousands of volunteer patients, which allow 
generating statistically information about safety and efficacy.  
To sum up, developing a new drug, from its original idea to generate a marketed 
product, is a complex process which can take at least 10 years, and it cost billions; 
moreover, approximately only 1 out of 20-25 drug candidates is approved, and eventu-
ally leads to a new marketed medicine. [Phrma.org] 
Despite all the available technology, the insights provided by in genomic research 
and the growing resources and founding, the number of new molecular entities 
(NMEs), that is, a medication containing an active ingredient that has not been previ-
ously approved for marketing in any form, had been decreasing in the early 2000s; 
probably, due to several facts, such as clinical failures, increasing demands by regula-
tory authorities, and the disconnection between business and research goals. [3, 4, 8] 
Fortunately, some new prospects are surfacing for the drug discovery process. In 
the last 5 years the number of NMEs approved by FDA has increased. More specifical-
ly, 51 new drugs were approved in 2014 (mostly for immunotherapy in cancer, diabe-
tes, and hepatitis C); the highest number since 1996, see Fig. 3. 
 
Fig. 3 - Average number of new medicines approved by the FDA per year- Adapted from phrma.org. 
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1.3   Computational drug discovery 
The advent of computers and computational methods has changed all aspects of drug 
research. The reality is that the use of computers reduced the time, the cost, and the 
risk of failure of drug research by up to 50%, allowing potent HITs be obtained in a 
matter of weeks. [5, 9] 
Different computational tools exist, and they can be used in various stages of drug 
discovery, from target identification to preclinical tests, which included: molecular dock-
ing, de novo design, quantitative structure-activity relationships (QSAR), pharmaco-
phore modeling, similarity searching, sequence-based virtual screening, etc. [5, 9] 
Moreover, algorithms to calculate molecular properties have been used in order to 
predict intestinal absorption and drugability, since oral ingestion is the most preferred 
route of drug administration, and these analyses avoid costly late-stage preclinical and 
clinical failures. [10] 
 
1.4   Orally delivered drugs 
In drug development, new drugs are designed and tested in a dosage form that is ad-
ministered by a specific route. If the most promising drug is unable to reach its target 
organ at a concentration sufficient to have a therapeutic effect, it will fail in clinical trials; 
thus, a successful drug must be able to overcome physical, chemical, and biological 
barriers that limit the access of foreign substances to the body.  
The routes of administration are normally chosen to take advantage of transport 
molecules that allow the drug to enter body tissues. From all the available routes, oral 
administration is usually the most desirable strategy, since it is more convenient, pain-
less, and allows self-administration. However, an orally administrated drug must resist 
the digestive tract degradation, it must be stable during its absorption across the gas-
trointestinal track epithelium, and it must resist to the first passage effect. 
All human cells and its organelles are surrounded by a lipid membrane, which is a 
dynamic and flexible structure consisting of phospholipids, glycolipids, and sterols. The 
membrane assumes a structure with a hydrophobic core and two hydrophilic surfaces 
due to the amphiphilic nature of membrane lipids. Biological membranes also contain a 
variety of proteins varying between 20 and 80% (w/w) that may span the membrane, or 
be exposed at the extracellular or intracellular membrane surface. [11-13] 
Although the hydrophobic core of a biological membrane consists of a barrier to 
drug transport, there are several known mechanisms of intestinal drug absorption: pas-
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sive diffusion (paracellular and transcellular transport), carrier-mediated transport, and 
active transport. 
Normally, the absorption of orally administered drugs occurs in the duodenum and 
small intestine; mainly, by passive diffusion, that is driven by a concentration gradient, 
and can occur by i) paracellular transport, when molecules cross the membrane be-
tween cell junctions, or ii) by transcellular transport, in which molecules cross the cyto-
plasm. [11, 12, 14]   
The type and rate of transport depends on molecules’ properties; for instance, lipo-
philic drugs, such as steroids, can cross the lipid bilayer easily, whereas hydrophilic 
drugs, such as mannitol, cannot cross the membrane, but can pass through gaps be-
tween cells of the intestinal mucosa. [14] Moreover, the drug’s acid dissociation con-
stants (pKa) and the pH gradient across the membrane may also affect drug’s diffusion 
through biological membranes, and because of that, drugs only cross the lipid mem-
brane in its neutral form; thus, weakly acids are better absorbed in the acidic environ-
ment of stomach, while weakly basic drugs are preferentially absorbed in duodenum, 
which has a basic environment. [15] 
However, drug permeability cannot be accurately estimated based solely on physi-
cochemical factors like pH, lipophilicity, or solubility. Over the past 15 years, many re-
searchers have attempted to understand which relevant molecular properties directly 
influence oral the drug-like behavior of compounds. Lipinski et al. were the first to point 
out trends between physicochemical and structural properties, and the absorption of 
known drugs, when he came out with the so-called “rule of 5”. Lipinski’s rules were de-
rived from a statistical analysis of a selected library of 2.245 compounds with superior 
physicochemical absorption properties that were believed to have entered phase II clin-
ical trials. On the whole, the ‘rule of 5’ associates four parameters with drugs’ permea-
bility: molecular weight, logP, the number of H-bond donors, and the number of H-bond 
acceptors. [16-18] 
Veber et al. have brought up another important contribution into this field with the 
analysis of trends in the properties of 1.100 drug candidates studied at Glax-
oSmithKline, GSK. Veber’s rules correlate drug’s low-bioavailability with high polarity, 
expressed as polar surface area or total hydrogen bond count, and high flexibility, ex-
pressed as measured by the number of rotatable bonds. 
Apart from Lipinski and Veber, other researchers have carried out analysis of the 
properties of marketed drugs and compounds under clinical investigation, and a thor-
ough summary of their works can be found in a review by Lajiness. [19] 
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1.5   Molecular Properties 
1.5.1   Molecular Weight 
One of the most important physicochemical parameters that has long been thought to 
disfavor compound's permeability is molecular weight, which has been increasing over 
the years, see Fig. 4. [8, 20] Moreover, it was demonstrated drug candidate leads tend 
to be heavier than the corresponding lead. [21]  
Lipinski et al. have shown molecular weights of compounds, in their selected li-
brary, were lower than those in the whole World Drug Index (WDI) data set, where his 
library was selected from, concluding good absorption or permeation are more likely 
when molecular weight is under 500 Da. [17] Apart from good permeation, a low mo-
lecular weight reduces drug’s clearance, because such molecules are less likely to be 
conjugated, particularly with glucuronate, and eliminated by biliary excretion, which in-
crease its bioavailability. [20] 
This rule seems to work very well for most cases; however, there are a few excep-
tions: renin inhibitors and HIV protease inhibitors are part of the bulk of drugs currently 
marked with molecular weights above 500 Da, see Fig. 5. Such out-of-rage behavior 
may result in part from conformation flexibility. [20] 
 
1.5.2   Octanol/Water partition coefficient - LogP 
Passive diffusion is highly influenced by lipophilicity, as previously stated. The lipo-
philicity of a substance can be quantified by the octanol/water partition coefficient 
(logP), which corresponds to the negative logarithm of the ratio of the concentration of 
the substance between two solvents, in the hydrophobic and aqueous phases, respec-
tively. The predictions of logP have been studied for more than 40 years by computa-
tional methods; therefore, huge databases of logP values are available. [8] The compu-
tational methodologies to work logP values out will be described later. 
A lower logP (hydrophilic) limits drug’s absorption and permeation; however, it has 
been reported that highly lipophilic compounds tend to have a higher incidence of non-
specific toxicity. [8, 13] Actually, according to Lipinski et al., only about 10% of com-
pounds in their selected library have a logP over 5. [17] In addition, they reported an 
increase in logP values of synthesized compounds in drug discovery programs at Pfiz-
er, just as the molecular weight trend. [8, 16] As a matter of fact, attention has been 
given to changes in logP values of drugs over time; see Fig. 4. [8] 
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Fig. 4 - Mean values for molecular weight, LogP, number of hydrogen bond donors and acceptors, number 
of rotatable bonds, and polar surface area for molecules published in Journal of Medicinal Chemistry in 
1959-2009 are shown as solid lines with squares. Blue squares indicate a statistically significant difference 
between the mean for a particular 5-year interval and the preceding interval. Red squares indicate that the 
difference was not statistically significant. Dashed lines indicate the median value for each property during 
the designated interval. The gray regions represent the 95% confidence interval for drugs launched during 
the same time period, with the dotted line representing the mean value for drugs during each 5-year peri-
od. Adapted from Walters et al.[8]  
  
10 FCUP/ICBAS 
Development of a computational protocol to study passive diffusion through biological membranes 
 
 
 
Fig. 5 - Distributions for compounds of therapeutic interest at earlier stages of development. (left) Mr distribu-
tion of a set of marketed drugs. (right) Certain classes of compounds, including the renin and HIV protease in-
hibitors, fall outside the Gaussian region of the distribution of Mr Values. Adapted from Navia et al. [20] 
 
The big issue in lipophilicity is the interaction between a drug and the hydrophobic 
bilayer core: hydrophilic compounds have weak interactions with the bilayer's hydro-
phobic core, whereas hydrophobic compounds have strong interactions, and tend to 
pass the membrane easier than hydrophilic compounds.  
 
1.5.3   Hydrogen Bonding Groups 
Hydrogen bond count is a parameter that directly influence molecule’s lipophilicity and 
structure; consequently, its permeability. The total number of hydrogen bonds is the 
sum of hydrogen donors and hydrogen acceptors, which are defined as any heteroa-
tom with at least one bonded hydrogen, and any heteroatom without a positive formal 
charge, respectively. [22] 
An excessive number of hydrogen donors or hydrogen acceptors hinders mole-
cules’ permeability. Lipinski et al. noted 92% of compounds in their selected library had 
5 or fewer hydrogen bond donors, and 88% of compounds had 10 or less hydrogen 
acceptors, [17] whereas Veber et al., in their turn, reported a sum of 12 or less hydro-
gen bond donors and acceptors for an ideal oral drug. [22] 
In addition, the mean number of hydrogen bonds had increased for 30 years follow-
ing 1960, but it appears to have stabilized since then, see Fig. 4. [8]  
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1.5.4  Rotatable Bonds 
Molecular flexibility is directly related to rotatable bonds, which can be defined as any 
single non-ring bond attached to a non-terminal heavy-atom. The amide C-N bonds are 
not counted because they have peptide-like bond characteristics due their high rota-
tional energy transition barrier. 
In medicinal chemistry, flexible molecules are often rigidified in order to reduce its 
conformational entropy, which allows an increase in its binding affinity and selectivity. 
When molecules are flexible there is a loss of entropy on binding or on membrane 
crossing due to conformational restriction; for this reason, if a molecule is rigidified, less 
entropy will be lost 
According to Veber’s analysis, for a rat oral bioavailability higher than 20-40% the 
number of rotatable bond needs to be 12 or less. [22] An increase in the average num-
ber of rotatable bonds over time was also noted; see Fig. 4. [8] 
 
1.5.5   Polar Surface Area 
The polar surface area, PSA, is defined as the area occupied by nitrogen, oxygen, 
phosphorus, and sulfur atoms, and hydrogen atoms attached to these heteroatoms. 
[23] Generally, calculated PSAs are correlated closely with the total hydrogen bond 
count; so, it has been reported by many authors a correlation between PSA and drug’s 
absorption. [24, 25] 
Palm et al. found drugs with a PSA under 63 Å2 were highly absorbed (>90%), 
while drugs with a PSA greater than 139 Å2 were poorly absorbed (<10%). [24] 
Subsequently, Veber et al. observed a PSA lower than or equal to 140 Å2 for mole-
cules with rat oral bioavailability higher than 20-40%. [22] 
A consistent increase in both the mean and median PSA over time was observed, 
once again, see Fig. 4. [8] 
 
1.5.6   Lipinski and Veber’s rules implementation 
To sum up, at this point, five parameters were described associated with drugs’ solu-
bility and permeability: molecular weight, octanol/water partition coefficient (logP), the 
number of hydrogen bonds, rotatable bonds, and polar surface area (PSA). 
Lipinski’s “rule of 5” states a high probability of poor oral bioavailability for a mole-
cule when its molecular weight is over than 500 Da, logP is over 5, the number of hy-
drogen bond donors is more than 5, and the number of hydrogen bond acceptors is 
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more than 10. Furthermore, compounds classes that are substrates of biological trans-
porters are exceptions to the rule.[17] 
Conversely, Veber’s rules described only two criteria for drugs with high rat oral bi-
oavailability: 10 or fewer rotatable bonds, and polar surface area less than or equal to 
140 Å2, or 12 or fewer hydrogen bond donors and acceptors. [22] 
Although Lipinski and Veber’s rules have had a huge impact on how the pharma-
ceutical industry evaluates drug’s behavior, caution should be taken. Despite its suc-
cess, the rule of 5 and Veber's rules are derived from simple statistical analysis. In ad-
dition, observations made by Veber and his co-workers were based on an internal da-
taset from GSK; consequently, other datasets should be evaluated, and those rules 
should be refined and improved. [19] 
In any case, pharmaceutical industry has been using computational methods to 
calculate molecular properties stated by Lipinski and Veber’s rules in order to predict 
intestinal absorption before investment, because they are often quicker and cheaper 
than the current experimental methods. 
 
1.6   What is this thesis about? 
Once drugs’ permeability is one of the major factors to decide whether a drug candi-
date could make the development continue, it appeared reasonable to attempt to un-
derstand the conceptual and theoretical framework of Lipinski and Veber’s rules; as 
well as to clearly establish the molecular properties that are essential for the passive 
diffusion of compounds through cell membranes. In addition, new and more predictive 
rules than current ones would be interesting to establish, in order to anticipate the pre-
diction of drugs candidates’ diffusion properties.
 
 
In this regard, a few oral drugs, for which chemical properties could be extracted 
from the literature, and for which our group has a vast experience, were selected, and 
their passive diffusion’s process were simulated. Not only did we obtain a complete 
structural characterization of the permeation process (including relevant interaction and 
drugs’ orientation through the bilayer), but also Gibbs free energy profiles for the diffu-
sion through cellular membrane models.  
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CHAPTER 2 
 
Computational Methodology 
 
‘So in short, what we develop is a way, which require a computer, to 
take the structure of a protein and then to eventually understand how 
exactly it does, what it does… you could use it, for example, to design 
drugs or just, like in my case, to satisfy your curiosity.’ 
Arieh Warshel,  
Nobel Prize in Chemistry, 2013 
 
 
Computational chemistry can be used to investigate the energetics associated 
with changes in both conformation and chemical structure. Recent advances in 
computational techniques, that make use of quantum mechanics (QM) or mo-
lecular mechanics (MM), now allow for a detailed understanding of the micro-
scopic events, at the atomic level, of chemical or biochemical processes. MM 
uses empirical energy functions, which include relatively simple terms to de-
scribe the physical interactions that dictate the structure and dynamic proper-
ties of molecules. On the other hand, applying other computational techniques, 
macroscopic events can also be understood. Molecular dynamics (MD) meth-
ods, for instance, calculates the time dependent behavior of a molecular sys-
tem, offering a great insight on how the systems works. 
 
 
 
 
2.1   Introduction 
Computational chemistry has emerged as a subfield of theoretical chemistry where 
mathematical methods are combined with fundamental laws of physics to solve chemi-
cally related problems. The real strength of computational chemistry is the ability to 
generate data, and thereby, predict structures and energetics of chemical systems, in-
cluding large-scale biological systems. In applying theoretical ideas using computers, 
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computational chemistry can help us to better understand the dynamic of chemical and 
biochemical events, some of them difficult to interpret until now.  
Currently, there are three popular computational classes of methods to approach 
hypothetical chemistry problems: i) quantum mechanics (QM), ii) molecular mechanics 
(MM), and iii) hybrid quantum mechanics/molecular mechanics (QM/MM) methods. 
Quantum chemistry is based on wave function determination by ab initio and semi-
empirical numerical techniques, or based on the electronic density-by-density function-
al theory (DFT); QM is primarily concerned with the numerical computation of molecu-
lar electronic structures. Ab initio (Latin term for ‘from the beginning’) methods are de-
rived directly from theoretical principles, with no inclusion of experimental data. They 
are based on wave function and try to resolve the non-relativist Schrödinger's equation 
to get the most accurate results for any kind of system; however, since they take 
enormous amounts of computer CPU time, memory, and disk space, they can be only 
used for small systems (typically less than one hundred atoms). Semi-empirical tech-
niques are based on the Hartree-Fock’s formalism, but use approximations from empir-
ical or experimental data to provide input into the mathematical models. The good side 
of semi-empirical calculations is that they are much faster than the ab initio calcula-
tions, and allow studying larger systems than ab initio methods (typically up to 1 thou-
sand atoms). In its turn, DFT methods are based on electronic density, and they are 
designed to determine the properties of a many-electron system by using density func-
tionals. They are less computational demanding and less accurate than ab initio meth-
ods of the same accuracy, but more demanding and accurate than semi-empirical 
techniques. [26] Similarly to ab initio methods, only small systems (less than three 
hundred atoms) can be studied by DFT methods.  
When a system is too large to be studied by ab initio, semi-empirical, or DFT meth-
ods, it is still possible to simulate its behavior by Molecular Mechanics (MM), that uses 
the laws of classic mechanics and a force field (FF) based on empirical parameters to 
explain and interpret the atoms and molecules’ behavior. [26] 
The work described in this dissertation is based on molecular mechanics; hence, in 
this thesis we will focus only on the description of MM-based notions and techniques, 
and not on quantum, semi-empirical or hybrid approaches. Indeed, the systems we 
purpose to study are too large and complex (water/membrane/drug) to be treated by 
QM-based approaches. However, quantum methods were used in systems’ parameter-
ization, especially to ascribe atomic point-charges to molecules. For this reason, only a 
small description of the QM-based procedure will be given in section 3.1. 
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2.2   Molecular Mechanics 
Many of the chemical or biochemical systems are too large to be considered by QM-
based methods, as was stated before. Fortunately, molecular mechanics can be ap-
plied to large-scale systems because it is a purely empirical method, which ignores the 
electronic degrees of freedom, and calculates the energy of a system as a function of 
the nuclear positions only. This conception greatly reduces the computational burden 
of an MM-based calculation. Although, in some cases, molecular mechanics can esti-
mate physical-chemical quantities as accurately as quantum mechanical calculations, it 
cannot provide properties that depend upon changes in the electronic distribution in a 
molecule. [26] 
The use of MM to study chemical or biochemical systems is possible due to the 
Born-Oppenheimer’s approximation, which assumes the motion of atomic nuclei and 
electrons in a molecule can be separated; therefore, is possible to consider energy as 
a function of the nuclear coordinates, which are stated by the laws of classical mechan-
ics. As a result, each atom is simulated as a single spherical particle, which is assigned 
a radius (typically the van der Waals radius), and a constant net charge, generally de-
rived from ab initio methods. Moreover, bond interactions like stretching bonds and an-
gle bending are treated by harmonic potentials with an equilibrium distance equal to 
the experimental or calculated bond length, see Fig. 6. [26] 
 
 
Fig. 6 - Schematic illustration of the most important interactions that contribute to a molecu-
lar mechanics force field: bond stretching, angle bending, torsional terms, and van der 
Waals and electrostatics interactions.  
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Essentially, a force field (FF) refers to an equation that uses those simple terms 
and parameters from experiment or more accurate methods, to calculate the energy of 
a molecule. Different force fields can be found in literature, and each one is specific for 
different kinds of molecules; however, most of them share the same mathematical 
terms, see equation 1: 
 
  𝑉! = 𝑉!"#$ + 𝑉! + 𝑉! + 𝑉!"# + 𝑉!" + 𝑉!"#$$    (1) 
 
The first three terms, Vbond, V𝜃, and V𝜔 describe the energy associated to the bond 
stretching between two atoms, the angle bending between three atoms, and the torsion 
energy for dihedral angles, respectively. These terms are only used to describe cova-
lently connected atoms. The fourth and fifth terms, Vvdw and Vel are descriptive of 
through-space interactions through non-covalent terms of van der Waals and electro-
statics interactions, respectively. Finally, the last term, Vcross, is related to the correlation 
of the bond-terms (Vbond, V𝜃, and V𝜔); however it is not often included in FFs because it 
is computational demanding. Indeed, Vcross only was found to be important in FFs de-
signed to predict vibrational spectra, and it is only included in a FF when an optimal 
performance must be achieved. [26] 
Force field applications have been extensively based on force field parameters’ 
transferability. The term 'transferable' implies that a set of parameters developed and 
tested on a relatively small number of cases should be transferable between different 
molecules with similar chemical structure, and could be applied to a much wider range 
of problems. Moreover, not only the force field parameters should be transferable be-
tween different molecules, but also it should be also applicable in systems in different 
physical conditions like pressure, temperature, or composition. In addition, a transfera-
ble force field should be properly validated for different thermodynamic properties. [26, 
27] 
The successful application of computational methods depending on the accuracy of 
the force field model has long been recognized. The most commonly used FFs for bi-
omolecular simulations are those included in the AMBER (Assisted Model Building with 
Energy Refinement), CHARMM (Chemistry at HARvard Macromolecular Mechanics), 
and GROMOS (GROningen Molecular Simulation) bundles. The AMBER FFs were ini-
tially designed for simulation of biomolecules like proteins, nucleic acids, and even car-
bohydrates. The first AMBER FF version used an ‘united-atom’ model; nonetheless, 
the latest versions make use of ‘all-atom’ representations, in which all the atoms in the 
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system, including hydrogen’s, are parameterized. Similarly, CHARMM FFs also use 
‘all-atom’ representations, but they are often seen as more flexible than AMBER FFs, 
since they were developed for a vast range of molecules, from small molecules to 
complex and solvated biological macromolecules. In its turn, GROMOS FFs are taking 
hold, once they are not only as flexible as CHARMM FFs, but also faster. [28-30] 
One of the FFs used in this work, which is compatible with the AMBER FFs, is a 
more generic force field for organic molecules, especially designed for the automated 
analysis of diverse libraries of a variety of organic and pharmaceutical molecules, 
called GAFF (General AMBER force field). The equation 2 is the potential energy func-
tion of GAFF, and each term will be described in next subchapter. [30, 31]  
 𝑉! = 𝑘!(𝑙 − 𝑙!)!!"#$% + 𝑘!(𝜃 − 𝜃!)!!"#$%& + 𝑘! cos 𝑛𝜔 − 𝛿 + 1!"#$%"&$ + 4𝜀!" !!"!!" !" − !!"!!" ! + !!!!!!"!!"!"!#"!$%     (2) 
 
Although CHARMM and GAFF include explicit hydrogen atoms, they have had 
problems to describe lipid bilayers in the isothermal−isobaric ensemble (NPT), which is 
the desired ensemble to perform simulations of lipid bilayers. Lipid molecules have an 
amphiphilic nature, and it has been difficult to study lipid bilayers in full atomistic detail, 
because if no surface tension was applied, or if the area of the membrane plane was 
not kept constant, the lipid bilayers often ended up in the gel phase instead of the ex-
pected fluid phase. 
In order to do reliable and realistic modeling of lipid bilayers, Jämbeck et al. have 
systematically derived and validated a force field, which they called Slipids (Stockholm 
lipids), which can reproduce a number of properties measured experimentally. Slipids 
includes parameters, for example, for unsaturated phosphatidylcholine and phosphati-
dylethanolamine lipids, sphingomyelin, phosphatidylglycerol, phosphatidylserine lipids, 
and cholesterol. [32-34] 
Furthermore, others FFs for more specific situations exist, like the MM (Molecular 
Mechanics) series (MM1, MM2, MM3, MM4) and OPLS (Optimized Potential for Liquid 
Simulations), which are often used in organic solvents’ simulations. [26] 
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2.3   Force Field's Parameters 
In this point, the individual terms of molecular mechanics force field it will be discussed 
in some detail, giving a selection of the various functional forms that are in common 
use. 
 
2.3.1   Bond stretching 
The potential energy curve for a typical bond is well described by the Morse potential, 
which has the form of equation 3: 
 
  𝑉! = 𝐷!(1 − 𝑒!!(!!!!))!   ,  (3) 
 
where l is the bond length, De is the depth of the potential energy minimum, and 𝑎 = 𝜔 𝜇 2𝐷! where µ is the reduced mass, and ω is the frequency of a particular 
bond’s vibration.  
Although the Morse potential is very accurate in describing a wide range of behav-
iors, from the strong equilibrium behavior to dissociation, is also computationally de-
manding; consequently, simpler expressions, like Hook's law formula, are often used. 
Therefore, bond stretching is described as a harmonic potential, in which the energy 
varies with the square of the displacement from the reference bond length l0, as dis-
played in equation 4:  
 
  𝑉! = !! (𝑙 − 𝑙!)!   ,    (4) 
 
in which l0	corresponds to the equilibrium bond length, the value that the bond adopts 
when all others terms in the force field are set to zero, and k	is the force constant. 
The use of Hook's law is possible because is a reasonable approximation to the 
shape of the potential energy curve at the bottom of the Morse potential, at the dis-
tances that correspond to bonding in ground state molecules, see Fig. 7. 
However, the harmonic potential is less accurate in regions far from equilibrium, 
and does not describe the best chemical behavior if bonds stretch are too far from the 
reference length. To overcome this problem, cubic and higher terms can be included 
and the bond stretching potential can be written as a truncation form from the Taylor 
expansion, equation 5, where 𝑉!!  and !!!!"  are zero. 
 𝑉! = 𝑉!! + !!!!" (𝑙 − 𝑙!) + !!!  !!!!!" (𝑙 − 𝑙!)! + !!!  !!!!!" (𝑙 − 𝑙!)!…  (5) 
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Fig. 7 - Comparison of the simple harmonic potential (Hook's law) with the Morse potential. 
 
2.3.2   Angle bending 
The angles' deviation from its reference value is also frequently described using the 
Hook's law or harmonic potential, like bond stretching, by: 
 
  𝑉! = !! (𝜃 − 𝜃!)!   ,    (6) 
 
were θ represents the angle between the atoms A, B, and C (see Fig. 7), θ0 is the ref-
erence value for the same angle, and k is the force constant. 
Once more, the accuracy of the force field can be improved using higher-order 
terms: 
 
  𝑉! = 𝑉!! + !!!!" (𝜃 − 𝜃!) + !!!  !!!!!" (𝜃 − 𝜃!)! + !!!  !!!!!" (𝜃 − 𝜃!)!… , (7) 
 
where 𝑉!!  and !!!!"  are zero. 
Nevertheless, when biological systems are being studied the use of harmonic terms 
for bond stretching and angle bending is sufficient, not only because higher-order 
terms required more computational power, but also because such simulations are per-
formed in the vicinity of room temperature; typically, at room temperature bonds and 
angles stay close to their equilibrium. [28] 
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2.3.3   Dihedral torsion 
The torsion angle or dihedral angle (ω) is the angle between the two planes defined by 
the atoms ABC and BCD, see Fig. 6. The angle  can vary between [0º, 360º] or [-
180º, +180º], and its energy is given by equation 8: 
 
   𝑉! = !! 𝑘!!"#$ 1 + cos (𝑛!𝜔! − 𝛾!)!    ,    (8) 
 
where ω represents the torsion angle between AB and CD bonds, kABCD is the force 
constant associated with the rotation, n is the multiplicity (the number of minima of the 
function as the bond is rotated through 360º), γ is the phase that defines the minimums’ 
position, and i	the number of dihedral angles of the system. The torsional energy varia-
tion as a function of the dihedral angle for the butane molecule can be observed in Fig. 
8. 
 
 
Fig. 8 - Torsional energy as a function of the rotation of the dihedral angle for the butane mole-
cule. A schematic illustration of the occurrence of the periodic structures, depending on the tor-
sional angle is also presented. 
 
2.3.4   Van der Waals energy 
The van der Waals energy, Vvdw, is described as the sum of attractive and repulsive 
forces between non-covalently interacting atoms. The attractive forces, also called dis-
persive forces, or London forces, are relevant only at short and medium ranges, and 
Vvdw tends quickly to zero for high inter-atomic distances. On the other hand, the repul-
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sive forces or Pauli’s repulsion are very short-range, and they are higher when two at-
oms come very close, and there is overlapping of their electronic densities (Pauli ex-
clusion principle). Moreover, for intermediate distances there are a certain attraction 
between electronic clouds of the atoms, promoted by instant dipole - induced dipole 
interactions, see Fig. 9. 
The van der Waals energy term can be mathematically described by Lennard-
Jones potential for a pair of atoms	i	and j, 
 
  𝑉!"# 𝑖, 𝑗 = 4𝜀!" !!"!!" !" − !!"!!" !    ,    (9) 
 
where −4𝜀!" !!"!!" !is the attractive term, 4𝜀!" !!"!!" !" is repulsive term, εij corresponds to 
the energy minima of the function, σ is the finite distance at which the inter-particle po-
tential is zero, and r is the distance between the particles. 
 
 
 
  
Fig. 9 - Graphical representation of the Lennard-Jones potential, which describes attraction and re-
pulsion between two particles. σ is the interatomic distance for which the potential energy is zero. The 
deeper the well depth (ε), the stronger the interaction between the two particles.
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2.3.5   Electrostatic energy 
The electrostatic energy, Vel, describes the non-covalently bonded interactions arising 
from the presence of permanent atomic charges, and its value is obtained according to 
Coulomb’s law, equation 10 and Fig. 10: 
 
  𝑉!" 𝑖, 𝑗 = !!!" !!!!!!"    ,    (10) 
 
in which qi and qj represent point charges of the atoms i and j, ε is the dielectric con-
stant of the medium, and rij the distance between atoms.  
 
 
Fig. 10 - Graphical representation of the Coulomb potential of particles with opposite 
charges.  
 
Differently from the other terms, Vel is not transferable between systems, because it 
is more variable, and cannot be reliably determined based on the type of atom, since 
point-charges greatly depend on the environment. [35] As a consequence, different 
methods to calculate Vel have been reported in literature, like the Mulliken population 
analysis, the CHarges from Electrostatic Potentials using a Grid-based (CHELPG) 
method, the Restrained ElectroStatic Potential (RESP) method, Merz-Kollman (MK) 
method, etc. [26] 
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2.4   Molecular Dynamics 
Molecular dynamics simulation (MD) is one of the principal tools in theoretical studies 
of biological molecules. This computational method simulates the dynamic behavior of 
a molecular system, from which detailed information on molecular properties can be 
calculated.  
The first MD simulation resulted from the pioneering applications to the dynamics of 
liquids by Alder and Wainwright, in the late 1950s. Due to the revolutionary advances 
in computer technology and algorithmic improvements, MD has subsequently become 
a valuable tool in many areas of physics and chemistry, and MD methods are, nowa-
days, routinely used to investigate the structure, dynamics, and thermodynamics of bio-
logical molecules and their complexes. [36] 
In MD simulations, the time evolution of a set of atomic positions are derived in se-
quence by applying Newton's equations of motion, equation 11, where for a particle i, 
ri, is its position vector, Fi, is the force acting upon i at time t, and mi is the particle’s 
mass. 
 
  𝐹! = 𝑚! !!!!(!)!!!     (11) 
 
Particles move in straight lines at constant acceleration, and after a time step, the 
new velocities, positions, and the instantaneous forces acting on particles are calculat-
ed by integrating equation 11 using the principle of conservation of linear momentum. 
However, due to the many-body nature of the problem, the equations of motion are 
discretized and solved numerically; therefore, the positions and velocities are propa-
gated with a finite time interval using numerical integrators. That is to say, the equa-
tions of motion are integrated by breaking the calculation into a series of very short 
time steps. At each step, the forces on the atoms are computed and combined with the 
current positions and velocities to generate new positions after the time interval. The 
resultant force, which acts on each atom, is also calculated according to the new atom-
ic positions, and this process is repeated until a desirable number of microstates are 
computed. In this way, MD generates a trajectory that describes how coordinates and 
momenta change with time, and the dynamic properties and events, which may influ-
ence the functional properties of the system, can be directly traced at the atomic level 
making MD especially valuable in molecular biology. [26, 36]  
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Simulation's trajectory is nothing but a set of microstates sharing the same thermo-
dynamic properties, which is known as an ensemble. An ensemble is defined accord-
ing to thermodynamic state functions that have values explicitly defined and fixed, and 
different ensembles exist: the canonic ensemble (NVT), where the number of particles 
(N), volume (V), and temperature (T) are fixed; the isothermal-isobaric ensemble 
(NPT), in which N, T, and pressure (P) are fixed; the microcanonic ensemble (NVE), 
with fixed N, V, and total energy (E); and the big canonic (µVT) in which the V, T, and 
the chemical potential (µ) are also fixed. In MD, ensemble’s choice depends on what 
we want to simulate. If we want to emulate a physiological condition, NPT would be the 
most realistic choice, since pressure and temperature of a closed system tend to be 
constant due to atmospheric pressure and physiological/room temperature of the sur-
roundings. The choice for the integration time interval (∆𝑡) is also essential for any mo-
lecular dynamics simulation, because a lower value for ∆𝑡 results in a more accurate 
simulation; unfortunately, a lower value for ∆𝑡 also results in a higher computational 
demand. Typically, the chosen value for ∆𝑡 corresponds approximately to one-tenth the 
time of the shortest period of motion, or smaller. In flexible molecules, the highest-
frequency vibrations are due to bond stretches containing a hydrogen atom. For in-
stance, a C-H bond vibrates with a frequency of approximately 10 fs; therefore, a value 
of 1 fs for ∆𝑡 is commonly used. However, these high-frequency motions are usually of 
relatively little interest, and have a minimal effect on the overall system's behavior. In 
order to decrease the computational burden, such vibrations can be restraint to their 
equilibrium value using algorithms such as SHAKE or LINCS, and a 2 fs value for ∆𝑡 
can be used without decreasing the simulation's accuracy. [26] 
To perform realistic simulations, it has to be accounted that an aqueous solution is 
the typical environment for biological macromolecules, and an atomically detailed rep-
resentation of the solvent (explicit solvent) is preferably used. However, because of 
limited computer memory and also to speed up the calculations, only a finite sample of 
an extended (infinite) system can be represented explicitly in a computer model. Thus, 
due to the finite size and surface effects of the system, caution should be taken in non-
bonding interactions' calculation. 
Short-range forces (van der Waals interactions) are described according to Len-
nard-Jones terms, which decay proportionally to r-6 at longer distances, whereas long-
range forces (electrostatic forces) vary with the distance proportional to r-1. Long-range 
forces are treated through periodic boundary conditions (PBC), which are imposed on 
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a system to deal with its finite size and surface effects, or the Particle Mesh-Ewald 
method (PME).  
PBC method allows representing simulation's cell as single cell in an infinite net-
work of its replicas, see Fig. 11, which needs to be large enough for molecules to not 
interact significantly with their replicas.  
Finally, PME method has been considered the best method to determine long-
range interactions in periodic systems. Essentially, the electrostatic problem is solved 
in two parts, and uses also a cut-off value as the PBC method. The difference is that 
outside the cut-off value the potential is not set to zero, but is solved using an approxi-
mate method, and inside the cut-off value the potential energy is calculated using the 
Poisson's equation. [26] 
 
 
 
Fig. 11 - Illustration of the PBC's principle: a particle, which goes out from the simulation box 
by one side, is reintroduced in the box by the opposite side (in the 3 dimension of space). Im-
age created using Bohemian Coding (2014) SKETCH (version 3.1.1) ’software'. 
 
2.5   Free Energy 
As was already mentioned in chapter 1, drug’s permeability limits the oral availability of 
drugs via cellular membranes, and is a major factor to decide whether a drug candidate 
could continue through development. As for many other chemical and biological pro-
cesses, permeability is governed by the change in free energy when drugs cross cell 
membranes. The ability to predict free energies, along selected degrees of freedom, 
offers a great insight how passive diffusion works, and this is achieved by the calcula-
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tion of the free energy differences between two states of the system. Besides, it may 
also be interesting to know how the free energy changes as a function of some inter- or 
intramolecular interactions, such as the distance between two atoms, or the torsion an-
gle of a bond within a molecule, which is achieved by Potentials of Mean Force’s calcu-
lations (PMF). [26] 
 
2.5.1   The Calculation of Free Energy Differences 
The Gibbs free energy of solute transfer between water and 1-octanol can be calculat-
ed from the partition coefficient between the 1-octanol and the water phases (the so-
called logP): 
 
  log𝑃(! !) = !!!"!!!!"#$!!.!"!!"    ,    (12) 
 
where ΔhydG is the hydration free energy,  ΔsolvG is the Gibbs free energy of solvation in 
1-octanol, R is gas constant, and T is the temperature. The solvation and hydration free 
energy is the work required to transfer a molecule from the gas phase into 1-octanol 
and water, respectively. Both are calculated according to the thermodynamic cycle 
shown in Fig. 12, and following equation 13 and equation 14: 
 
  Δ𝐺!"#$ = Δ𝐺! + Δ𝐺! − Δ𝐺!   ,    (13) 
 
   Δ𝐺!!" = Δ𝐺! + Δ𝐺! − Δ𝐺!   ,    (14) 
 
where ΔG1	is the work required to remove all the internal non-bonded interactions in the 
compound in vacuum,  ΔG2	 	and ΔG3	  are the work required to remove solute-solvent 
and the solute-intramolecular interactions, respectively. This is achieved by gradually 
mutating all atoms in a given compound (state A) into ‘dummy’ atoms (state B). In prac-
tice, a ‘dummy’ atom has its non-bonded interaction parameters (Lennard-Jones and 
electrostatics) set to zero. ΔG4, which appears twice in the cycle, is the work required to 
transfer the ‘dummy’ particle from vacuum to water or 1-octanol; however, the term is 
zero, because the molecule does not interact with the rest of the system. [37, 38] 
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Fig. 12 - Thermodynamic cycle for the determination of solvation free energies.  ΔGHYD	and  ΔGSOLV	are 
calculated using a non-physical path involving  ΔG1,  ΔG2,  ΔG3, and ΔG4. The transfer free energy,  ΔGTRANS, 
can be obtained from the difference between ΔGHYD	and  ΔGSOLV. 
 
Different methods have been proposed for calculating the difference in free energy 
of the system between state A and state B, like Thermodynamic integration (TI), Free 
Energy Perturbation (FEP), Bennett acceptance ratio (BAR), Multistate Bennett ac-
ceptance ratio (MBAR), etc.  
The BAR method might be less intuitive and more difficult to implement; however, it 
is less computational demanding than FEP, and it has been shown to be more efficient 
than TI.[39] BAR is a perturbation method, using the overlap between individual states, 
that was developed by Bennett[40] in 1976. Bennett showed the free energy difference 
change between state A and B is a function of a coupling parameter λ, which indicates 
the level of change that has taken place between the two states. At the end of the con-
ducted simulations conducted at different values of λ, a ∂H/∂λ curve is plotted, from 
which ΔGAB	is derived. The free energy difference is then obtained according to: 
 
  Δ𝐺!"!"# = −𝑘𝑇 𝑙𝑛 !!!!    ,    (15) 
 
where k is the Boltzmann constant, T is the temperature, and NA and NB represent the 
number of coordinate frames at  λA and  λB respectively.[41]   
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2.5.2   Potentials of Mean Force 
Differently from BAR method, the potential of mean force (PMF) method is one ap-
proach to describe how the free energy changes as a particular coordinate is varied. 
Formally, a conventional method for calculating the free energy, G(ξ), as a function 
of a reaction coordinate,	 ξ, relies on obtaining the probability density function,	P(ξ), of 
finding the system in the states corresponding to different values of	 	 ξ, and to exploit 
the relation: 
 
  𝐺 𝜉 = −𝑘𝑇  𝑙𝑛𝑃 𝜉 + 𝐶   ,    (16) 
 
where k is the Boltzmann constant, T	is the temperature, and C is an arbitrary constant 
often chosen so that the most probable distribution corresponds to a free energy of ze-
ro. Unfortunately, this approach may be inefficient if there are considerable free energy 
barriers along ξ; however, this method can be improved on its efficiency and accuracy 
by modifying the Hamiltonian of the system by a biasing potential chosen such that 
sampling of ξ becomes more uniform. [42, 43] 
 
2.5.3   Umbrella Sampling 
Developed by Torrie and Valleau[44], umbrella sampling is the most established tech-
nique to determine PMF values along a reaction coordinate by adding a biased force. 
To ensure sampling in all regions, the reaction coordinate is split into a number of win-
dows, and a bias function is applied to keep the system close to the reference point for 
each window, which are run in an independent simulation. Often, a simple harmonic 
potential is used, which allows for oscillation within each window that results in a set of 
overlapped biased probability distributions; see Fig. 13. [45] Rosta et al. have analyzed 
the difference between the average distances of structures, and conclude the path to 
be continuous if the difference did not exceed twice the sum of the standard deviations 
of distances in the two neighboring windows. [45, 46] 
As soon as all windows have been simulated, the free-energy differences are com-
bined to generate a global free energy profile. Using techniques like Weight Histogram 
Analysis Method (WHAM), the effect of the bias potential can be taken out, and the re-
sults combined to minimize statistical error, resulting in an unbiased probability distribu-
tion, which gives the PMF, see Fig. 14. Overlap between windows is required by 
WHAM analysis, and the sampling’s quality is as better as well the phase space in 
sampled in each window. If the reaction coordinate misses important structural chang-
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es it can lead to artificial lowering or raising of the result obtained by umbrella sam-
pling.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Fig. 13 - The figure illustrates the umbrella sampling windows’ principle. A pulling simulation allows for a 
generation of a series of microstates in specific points along the reaction coordinate (ξ). These mi-
crostates are extracted after the simulation is complete (dashed arrows), and independent simulations 
are conducted within each sampling window, with the molecule center of mass restrained in that window 
by a harmonic biasing potential. At the bottom is shown the ideal result as a histogram of configurations, 
with neighboring windows overlapping, such that a continuous energy function can later be derived from 
these simulations. Adapted from ‘Umbrella Sampling Tutorial’ from Justin Lemkul.[47] 
Fig. 14 - Umbrella sampling is a method that confines the molecule of interest into a set of configura-
tions (represented by x1, x2, and x3) along the reaction coordinate (ξ) (on the left). After the simulations’ 
completion, the free energy curves (dashed lines) are combined into a global free energy curve (solid 
line) (on the right). E1, E2, and E3 represent the PMF of configuration x1, x2, and x3, respectively. Adapted 
from ‘Computation of Potentials of Mean Force in GROMACS’ from Justin Lemkul.[48] 
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CHAPTER 3 
 
Line of Work 
 
In general, the work described in this thesis took place in three phases. Firstly, 
a small library of compounds was selected and parameterized, and free energy 
calculations, in water and in 1-octanol, were computed in order to validate the 
force field that was being used. Secondly, a DOPC/water membrane model 
was constructed, and umbrella sampling simulations were performed for three 
molecules: caffeine, nelfinavir, and atorvastatin. These umbrella sampling 
simulations helped us to attain the free energy profile for the drugs’ permeation 
through the membrane. Thirdly, nelfinavir and atorvastatin’s rotatable bonds 
and PSA were determined. In this section, the protocol for each phase will be 
detailed. 
 
 
 
 
3.1   Parameterization 
A small library of compounds, for which solvation free energies could be extracted from 
the literature, was set up, and free energy calculations for each compound (neutral 
form), in water and in 1-octanol, were performed. Therefore, a few compounds, for 
which the chemical structures are shown in Fig. 15, were chosen from Nicholls et al. 
[49], and their primordial structures (mol2 files) were extracted from the ZINC database 
(zinc.docking.org). 
After the compounds’ selection, they were gas-phase parameterized, using the An-
techamber and Gaussian 03 programs. Antechamber is an auxiliary module in AMBER 
(“Assisted Model Building with Energy Refinement”) designed to be used with GAFF in 
order to identify bond and atom types, judge atomic equivalence, generate residue to-
pology files, and find missing FF parameters and propose reasonable alternatives. [50] 
In its turn, Gaussian 03 is an electronic structure program, based on the fundamental 
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laws of Quantum Mechanics (QM), and it is used by scientists to predict the energies, 
molecular structures, and vibrational frequencies of molecular systems, along with nu-
merous molecular properties derived from these basic computation types. 
Gaussian was then used to perform a geometry optimization on each molecule in 
order to determine the minimum energy structure, in a process that was carried out us-
ing the HF/6-31G(d), a Hartree-Fock theory that uses a medium-sized basis set. The 
Fig. 15 - Squematic representaiton of the compounds that were selected to make part of the compound's 
library for validation: (A) aspirin; (B) caffeine; (C) diflunisal; (D) D-glucose; (E) D-xylose; (F) ibuprofen; (G) 
glycerol; (H) octafluorocyclobutene; (I) 4-nitroaniline; (J) naproxen; (K) hexachloroethane. 
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RESP method to derive a set of atom-centered point charges, which best reproduces 
the electrostatic potential of the molecule, was also used. [51] 
After compounds’ parameterization, the structure and topology files were converted, 
using the ACPYPE toll, into other files compatible with GROMACS (Groningen MA-
chine for Chemical Simulation) program. ACYPYPE is an ANTECHAMBER-based toll 
that calculates partial charges and generates topology and parameters in different for-
mats for different MM programs.[52] GROMACS is a very fast program for molecular 
dynamics simulation; although, it does not have a force field of its own, it is compatible 
with commonly FFs like AMBER or GROMOS. [53] Moreover, the Slipids force field, 
which is used in this work for the simulation of biological membranes, was designed 
exclusively in GROMACS format. Indeed, in this work, all molecular simulations were 
performed using the GROMACS 4.6.1 package. 
 
3.2   Free energy calculations 
For each parameterized molecule, a cubic water box of at least 1.5 nm between any 
atom of the molecule and the edge of the box was built, using editconf and genbox 
tools from GROMACS (see Fig. 16). The TIP3P[54] water model was chosen for this 
regard. 
As it was discussed before, free energy calculations describes the transformation 
from state A (λ=0) to state B (λ=1); so, the first step in planning free energy calculations 
Fig. 16 - Squematic representation of a cubic water box. Image creat-
ed using Bohemian Coding (2014) SKETCH (version 3.1.1) ’software'. 
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is how many λ point will be used. In this work, Coulombic and van der Waals' interac-
tions were decoupled, and an equidistant λ spacing of 0.05 was used, that is to say, 20 λ were used. 
For each value of λ, in which λ=0 refers to a fully interacting solute and λ=1 to a 
noninteracting solute, a complete workflow was conducted: steepest descents minimi-
zation of 5000 steps, L-BFGS minimization[55] of 5000 steps, NVT equilibration of 100 
ps, NPT equilibration of 100 ps, and MD production under the NPT ensemble of 5 ns. 
Two energy minimization procedures were used, since the results are more accurate 
when they are used together.  
The integration of Newton's equations of motion was carried out using an accurate 
leap-frog stochastic dynamics (SD) integrator[56] with a time step of 2 fs. Short-range 
non-bonded interactions were cut off at 1.0 nm, with long-range electrostatics calculat-
ed using the particle mesh Ewald (PME) algorithm. Dispersion correction was applied 
to energy and pressure terms to account for truncation of van der Waals terms. Period-
ic boundary conditions were applied in all directions. Hydrogen bonds were constraint 
using the LINCS (LINear Constraint Solver) algorithm[57]. Temperature coupling was 
implicitly handled by de SD integrator with a time constant of 1 ps, and a reference 
temperature of 298.15 K. For constant pressure simulations the Parrinello-Rahman[58] 
barostat with a time constant of 0.5 ps, a reference pressure of 1 bar and an isothermal 
compressibility of  4.5 ×10-5 bar -1 was used to enforce pressure coupling. 
The use of the ‘soft-core' potentials is important to highlight. In the transformation 
process between states with different λ values, the λ dependence of the Lennard-Jones 
potential is interpolated between the neighboring states via this 'soft-core' expression, 
which allows to eliminate singularities in the calculation as the Lenard-Jones interac-
tions are turned off. Consequently, a 'soft-core' parameter of 0.5 and a 'soft-core' σ val-
ue of 0.3 nm were used. [37]  
Finally, data analysis was conducted using the GROMACS tool g_bar, which uses 
the BAR method for calculating free energy differences. The final error estimates were 
obtained from multivariate analysis of multiblock analysis over 500 blocks. 
In addition, ‘reverse’ simulations for caffeine and D-glucose were performed. In this 
context, ‘reverse’ means a coupling free energy calculation instead, in which the trans-
formations occurs from a non-interacting solute to a fully interacting solute. Discrepan-
cies between forward and reverse transformations yield the reaction's hysteresis, which 
constitutes a measure of systematic errors in the free energy calculation. Moreover, an 
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extended free energy calculation of 20 ns per λ for D-glucose was performed, because 
hysteresis tends to increase with the increase in the simulation’s time. [59] 
The same process used to calculate free energies in water, was also used to calcu-
late free energies in 1-octanol. First, the 1-octanol molecule was parameterized accord-
ing to the parameterization protocol described earlier; secondly, a system in which a 
drug is solvated by 1-octanol was built by the Packmol (Packing Optimization for Mo-
lecular Dynamics Simulations) [60, 61] program. Packmol packs molecules in defined 
regions of space, and guarantees that short repulsive interactions do not disturb the 
initial stage of simulation. Basically, through Packmol, a single 1-octanol molecule was 
replicated along the x and y axes until a rectangular grid of 300 1-octanol’s molecules 
was obtained [62]  
Before free energy calculations, a geometry optimization was performed in order to 
eliminate bad contacts, through a complete workflow: steepest descent minimization of 
2000 steps, NVT equilibration of 250 ps, NPT equilibration of 500 ps, and MD produc-
tion under NPT ensemble of 1 ns. The integration of Newton's equations of motion was 
carried out using a leap-frog MD integrator with a time step of 2 fs. Short-range non-
bonded interactions were cut off at 1.0 nm, with long-range electrostatics calculated 
using the particle mesh Ewald (PME) algorithm. Dispersion correction was applied to 
energy and pressure terms to account for truncation of van der Waals terms. Periodic 
boundary conditions were applied in all directions. Hydrogen bonds were constraint 
using the LINCS (LINear Constraint Solver) algorithm[57]. Temperature coupling was 
handled by V-rescale thermostat (a modified Berendsen thermostat[63]) with a time 
constant of 1 ps, and a reference temperature of 298.15 K. For constant isotropic pres-
sure simulations the Parrinello-Rahman[58] barostat with a time constant of 1 ps, a ref-
erence pressure of 1 bar and a isothermal compressibility of 7.64 ×10-5 bar -1 [64] was 
used to enforce pressure coupling. After that, free energy calculations, according to the 
same simulation conditions for the free energy calculations in water, were performed, 
and data analysis was also conducted through the g_bar tool. 
 
3.3   Setting up of the membrane system 
The lipid membrane system was built in several steps. First, the lipid bilayer was built 
using a Membrane Builder web-based graphical user interface, called CHARM-GUI[65-
68]. The Membrane Builder generates a series of CHARMM inputs necessary to build 
a protein/membrane complex for molecular dynamics simulations. Therefore, a DOPC 
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lipid membrane with 100 DOPC’s molecules per leaflet and a water box thickness of 8 
nm was built, see Fig. 17. Next, the drug was included in the system, 5 nm away from 
the DOPC bilayer, and after that, using the genbox tool. TIP3P[54] water molecules 
filled the 8 nm water box, thus establishing a solvated bilayer model. Moreover, Na+ 
and Cl- ions were added, using genion tool, to satisfy a saline concentration of 0.154 M 
of NaCl, in order to mimetize physiological conditions. 
Three compounds were studied in this part of the work: caffeine, nelfinavir, and 
atorvastatin. Caffeine was chosen to optimize protocols since its PMF profile can be 
found in the literature, whereas nelfinavir and atorvastatin were chosen because they 
have many rotatable bonds, which makes them an interesting case of study. Moreover, 
these molecules have different permeability: caffeine has high permeability, nelfinavir 
has moderate permeability, and nelfinavir has low permeability. Besides, our group has 
Fig. 17 - DOPC's membrane representation, with 100 DOPC's molecules per 
leaflet and a water's thickness of 8 nm. 
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extensive experience in working with nelfinavir[69, 70]. The chemical structure of caf-
feine is represented in Fig. 15.B, and the chemical structure of nelfinavir and atorvas-
tatin is represented in Fig.18. The chemical and physical properties of these molecules, 
which are important for Lipinski and Veber’s rules, are shown in Table I.  
 
The system was then equilibrated through a complete workflow: steepest descents 
minimization of 2000 steps, NVT equilibration of 250 ps, NPT equilibration of 1 ns, and 
MD production under the NPT ensemble for 40 ns. The integration of Newton's equa-
tions of motion was carried out using a leap-frog MD integrator with a time step of 2 fs. 
Short-range non-bonded interactions were calculated using the Verlet cut-off 
scheme[71] and a cut off distance of 1.2 nm, with long-range electrostatics calculated 
using the PME algorithm. The Verlet cut-off scheme is a requirement to use GPU ac-
celerators for running MD simulations, allowing the nonbonded interactions to be calcu-
lated on the GPU, whereas bonded and PME interactions are calculated on standard 
CPU hardware. Dispersion corrections were applied to energy and pressure terms to 
account for truncation of van der Waals terms. Periodic boundary conditions were ap-
plied in all directions. Hydrogen bonds were constraint using the LINCS algorithm[57]. 
Temperature coupling was handled by Nosé-Hoover[72, 73] thermostat with a time 
constant of 0.5 ps, and a reference temperature of 310 K, whereas semiisotropic (sep-
arate pressure coupling in xy and z separately) pressure coupling was handled by the 
Parrinello-Rahman[58] barostat with a time constant of 10.0 ps, a reference pressure of 
Fig. 18 - Nelfinavir (A) and Atorvastatin’s (B) chemical representations. 
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1 bar, and an isothermal compressibility of 4.5 ×10-5 bar -1 (same as for water) was 
used. 
Next, to verify whether the systems were well equilibrated several parameters were 
analyzed: the deuterium order parameters of the acyl chains, the density of the mem-
brane environment, the area per lipid’s headgroup, and the bilayer’s thickness. These 
will be thoroughly described and presented in the results section of this thesis. 
 
3.4   Calculations of Potentials of Mean Force 
As it was described in section 2.10.3, to conduct umbrella sampling simulations it is 
necessary to generate a series of configurations along a reaction coordinate ξ, which is 
accomplished by ‘pull’ simulations. During a pull simulation forces or constraints are 
applied between the center of mass of one or more pairs of groups of atoms. Thus, to 
generate the configurations we had to choose and defined a series of options for dif-
ferent settings that GROMACS offer us to perform pulling simulations. In this work it is 
desired that a molecule cross the membrane; so, technically, the pulled group (the 
drug) has to cross the plane of the reference group (the DOPC membrane); conse-
quently, one of the most important settings in pulling simulations is pull geometry, that 
is to say the path (direction and final position) that the drug has to follow. GROMACS 
offers us different pull geometries, and two of them were used in this work: the position 
geometry, and the cylinder geometry. For both pull geometries used, several simula-
tions, varying the simulation's time (0.5-1 ns), the force constant for pulling (10 -100 
kcal•mol-1), and the pull rate (0.1, 0.01, or 0.001 nm•s-1), were performed until a com-
plete crossing through the membrane had occurred. The pull simulation was run with 
the same MD setup used in section 3.3. 
Table I - Relevant chemical and physical properties for Lipinski and Veber’s rules extracted from chemicalize.org by 
ChemAxon. 
 
 
Molecular weight 
/ 
g•mol-1 
 
log P 
 
Hydrogen bond 
donor count 
 
Hydrogen bond 
acceptor count 
 
Rotatable bond 
count 
 
PSA / 
Å2 
Caffeine 194.19 -0.07 0 3 0 58.44 
Nelfinavir 567.78 4.72 4 6 10 101.90 
Atorvastatin 558.64 5.39 4 6 12 111.79 
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After that, frames for defining the umbrella sampling windows, with 0.1 nm spacing 
were extracted from the pull's trajectory files, for every 0.1 nm of the drug's progres-
sion. Some of these frames were then submitted to a MD simulation with only a NPT 
equilibration of 1 ns, and MD production under NPT ensemble of 5 ns. Many of the 
simulation’s parameters were the same as in the pull simulation, with the exception of 
the ‘pull rate’, which was set to zero to hinder the configuration’s movement along the 
reaction coordinate. 
At the end of each all umbrella sampling simulation, the PMF and the configura-
tions' histograms were extracted using the WHAM method, which is included in 
GROMACS as the g_wham utility. 
 
3.5   Rotatable bonds and polar surface area characterization 
To characterize rotatable bonds of nelfinavir and atorvastatin, a 10 ns simulation for 
each molecule in a water box was performed, using the same simulation’s setup de-
scribed in section 3.3. The value of each dihedral angle was calculated using the 
g_angle GROMACS tool for the last 5 ns of each simulation. Along with rotatable 
bonds, the PSA was calculated from that simulation using the g_sas GROMACS tool. 
From g_sas, we got a file containing all atoms’ area, but only oxygen, nitrogen, and 
sulfur were taken into account.  
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CHAPTER 4 
 
Results and Discussion 
 
4.1   Free energy 
Hydration and 1-octanol solvation free energies were estimated for a set of small com-
pounds (Fig. 15 in section 3.1), in order to validate the FF’s parameters. The purpose 
of the validation process is to test whether the FF is capable of reproducing these 
thermodynamic properties. If that happens, the FF must be also capable of reproducing 
the PMF profiles accurately, since the water is the same and the 1-octanol is analo-
gous to the hydrophobic core of the membrane. Hence, we compared our computed 
free energy values with those that made part of the SAMPL experiment, which was de-
signed as a blind challenge, where the actual experimental values of the compounds 
are withheld from participants until after predictions have been made.[74] The hydra-
tion free energy values that were determined using the BAR method are shown in Ta-
ble II. The standard deviation (sd) values for ΔGAB are important to highlight; these val-
ues were estimated from multivariate analysis of a multiblock analysis of 500 blocks, 
assuming the blocks are independent, and taking into account time correlation.  
Although, the reverse process (coupling) should be the correspondent symmetrical 
value of the decoupling process (assuming reversibility), coupling free energy calcula-
tions for caffeine and D-glucose were performed to find the reaction's hysteresis value, 
which constitutes a measure of the error in the free energy calculation. Mathematically, 
the hysteresis is the difference between coupling and decoupling processes, and if its 
value is markedly larger than the estimated statistical errors, it is usually indicative of 
ergodicity issues during the transformations. [59] As can be noted when looking at Ta-
ble II, the hysteresis values were almost zero, which means the systematic error of our 
free energy calculations was very small; however, because hysteresis tends to in-
crease with the increase in the simulation’s time[59], an extended free energy calcula-
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tion of 20 ns for D-glucose was performed. In the end, both simulations yielded the 
same result. Although, the hysteresis values obtained were negligible, and statistical 
errors were small, this does not imply that the calculated free energy difference is accu-
rate, because it may be burdened with other systematic errors, due, for example, to 
unsuitable potential energy functions. Furthermore, the system may have been con-
fined to a sub-region in the physical space. [59] 
To confirm whether free energy calculations are accurate, it is necessary to com-
pare the results obtained with experimental data extracted from literature. A difference 
of 1.15 kcal•mol-1, on average, between experimental values and the values obtained 
computationally can be observed also from Table II. This average value, which was 
obtained by the arithmetic mean calculation of the values for all compounds except 
Molecule 
∆GHyd (Calc) / 
kcal•mol-1 
∆GHyd (Expt[49]) / 
kcal•mol-1 
 | ∆GHyd (Calc) - ∆GHyd (Expt) |  / 
kcal•mol-1 
 
Caffeine -14.46 ± 0.03 -12.82 
 
1.64 
 14.43 ± 0.03  b  
 
 
D-glucose -23.78 ± 0.08 -25.44 
 
1.66 
 -23.88 ± 0.05 
a  
 
 
 23.84 ± 0.13  b  
 
 
 23.90 ± 0.05  a,b  
 
 
D-xylose -19.68 ± 0.08 -20.50 
 
0.82 
Glycerol -14.01 ± 0.04 -13.92 
 
0.09 
Hexachoroethane    0.57 ± 0.03 -0.28 
 
0.85 
Naxoprene -11.60 ± 0.04 -10.35 
 
1.25 
Uracil -15.32 ± 0.03 -16.06 
 
0.74 
4-Nitroaniline -12.44 ± 0.04 -9.89 
 
2.55 
Aspirin -12.94 ± 0.03 -12.33 
 
0.61 
Ibuprofen   -8.93 ± 0.04 -7.00 
 
1.93 
Octafluorocyclobutanol   -2.94 ± 0.02 -3.40 
 
0.46 
Diflunisal -11.78 ± 0.05 -7.63 
 
4.15 
Table II - Estimated values of hydration free energy, experimental free energy values, and difference be-
tween computed and experimental values. 
a simulations of 20 ns 
b reverse simulation 
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kcal•mol-1 
Diflunisal, which was statistically considered an outlier (see Fig. 19). Indeed, Diflunisal 
has two atoms of fluorine, and since polarization effects are important when dealing 
with halogens and since these are not accurately described by classical, fixed-charged 
FFs, it could justify the outlier characteristics of Diflunisal.[75] However, this average 
value was considered acceptable, which supports the accuracy of the GAFF force field 
in describing hydration free energies for this subset of compounds. Obviously, this is a 
reduced dataset for assessing on the accuracy of a force field. Hence, we are working 
to expand the dataset of compounds to be tested. Furthermore, though it would be in-
teresting to calculate hydration and 1-octanol solvation free energies for nelfinavir and 
atorvastatin, such calculations would take too long, and there are no experimental data 
available in the literature. 
Regarding the free energy calculations in 1-octanol, the sd values for ΔGAB were 
also estimated from multivariate analysis of a multiblock analysis of 500 blocks, assum-
ing the blocks are independent, and taking into account time correlation. In Table III the 
results of 1-octanol solvation free energy calculations in 1-octanol and the experimental 
1-octanol solvation free energy values are shown. These experimental values were 
calculated according to equation 12 (see section 2.10.1), and using the logP and hy-
dration free energy experimental values. The logP values were also obtained according 
to the same equation, and they can be found in Table IV. Comparing the obtained 1-
octanol solvation free energy values to the experimental ones, there is a discrepancy 
on average of 2.33 kcal•mol-1 between them. Regarding the logP values, we obtained 
consistent values for the two molecules with the highest logP (caffeine and D-xylose), 
and for the two molecules with lower logP values, though there is a discrepancy be-
tween these last two molecules. We assume that this could be attributed to the short 
time of simulation (5 ns / λ) and/or to the parameters for 1-octanol. Thus, to improve 
the free energy calculation in 1- octanol, it must be necessary to increase the simula-
tion’s time in 20 ns or more per λ, and/or improve the parameters for 1-octanol. Moreo-
ver, it would be necessary to increase the number of compounds to be tested. As a  
Fig. 19 - Hydration free energy values distribution. The median value is 1.05. 
0 1 2 3 4
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matter of fact, free energy calculations in 1-octanol were only performed for four com-
pounds due to the computational demand required for each free energy calculation. 
Despite the discrepancy between experimental and computed logP values, that 
needs to be explored for a larger number of compounds, we proceeded with the per-
meation studies through the membrane. These less promising results could be indica-
tive that GAFF is unable to accurately describe the free energy for different phases. 
However, we cannot markedly state such hypothesis without an extended validation 
considering numerous compounds. Numerous aspects led us to pursue with GAFF: 1) 
the computed hydration free energies were good, 2) the SLIPID parameters have been 
extensively validated, contrarily to 1-octanol parameters; and 3) this less good results 
for logP computation could be indicative of not enough sampling. We have then decid-
ed to continue with GAFF for the subsequent evaluations. Another main reason is due 
to the compatibility between parameters; by using other MM parameters and/or energy 
functions, from other philosophies, this could lead to increased errors due to FF incom-
patibility. Normally, the combination between different FF is not advisable without 
proper validation. 
 
Molecule ∆Gsolv (Calc) / kcal•mol-1 
∆Gsolv (Expt) / 
kcal•mol-1 
| ∆Gsolv (Calc) - ∆Gsolv (Expt) |  /  
kcal•mol-1 
 
Caffeine -17.47 ± 0.05 -12.72 4.75 
D-glucose -22.50 ± 0.32 -20.99 1.51 
D-xylose -18.28 ± 0.08 -19.03 0.75 
Uracil -15.33 ± 0.04 -13.01 2.32 
Table III - Estimated values of ∆Gsolv in 1-octanol, calculated experimental ∆Gsolv in 1-octanol val-
ues, and the difference between them. 
 Table IV - Estimated logP values, experimental logP values, and the difference between them. 
Molecule logP (Calc) logP (Expt)  logP(Calc) - logP(Expt) 
 
Caffeine 2.192 ± 0,008 -0.07 
 
2.26 
D-glucose -0.932 ± 0,004 -3.24 
 
2.31 
D-xylose 0.0738 ± 2 x10
-5
 -1.07 
 
1.08 
Uracil -1.019 ± 0,006 -2.22 
 
1.20 
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4.2   Setting up of the membrane system 
Cell membranes have very complex compositions, and for mammalian cell mem-
branes, phosphatidylcholine (PC) glycerophospholipids are the most abundant. In the 
present work, we carefully choose to employ a dioleoylphosphatidylcholine (DOPC) 
bilayer in our observations, because it had been one of the most studied glycerophos-
pholipidic bilayer systems. Moreover, DOPC has a transition temperature of -16.5 ºC, 
which means that DOPC is in the fluid phase state at room temperature, and is ideal 
for studies at physiologic temperature.[76] To confirm whether the simulated mem-
brane systems were well equilibrated, several parameters were analyzed and com-
pared with values found in literature: bilayer thickness, carbon–deuterium order pa-
rameters, and area per lipid. 
Bilayer thickness can be obtained from the density profile considering the hydrated 
system, by calculating the peak-to-peak distance between phosphate groups’ density 
(see Fig. 20) [33, 77]. The bilayer thickness’ values for each membrane system over 
the last 10 ns of the MD runs are shown in Table V. When we compare these values to 
the experimental one, 3.69 nm (30ºC) [78], we see that these are very similar and that 
minor differences could arise from different temperature settings.  
In the liquid crystalline phase, the lipid tails are conformationally disordered and flu-
id. To verify whether the membrane models had entered into a gel phase during the 
simulation, order parameters for the acyl chains were determined. They measure the 
disorder of the acyl chains and can be related to experimental carbon–deuterium order 
parameter (SCD) of the deuterated carbons in the hydrocarbon chains (representing the 
relative orientation of the carbon–deuterium bonds). [77] The calculated values for the 
sn-1 and sn-2, over all lipid acyl chains and for each membrane system, are plotted in 
Fig. 21 as a function of carbon atom number, starting from the atom closest to the 
headgroup, averaged over the last 10 ns of the MD runs. In all membrane systems the 
SCD values are smaller than 0.30, which is characteristic of a disordered hydrocarbon 
region. In addition, it can be observed, in Fig. 21, a dip in the values that correspond to 
the unsaturated carbon atoms present in the DOPC acyl chains in positions 9 and 10. 
[77] 
Finally, the area per lipid is another useful quantity to evaluate the bilayer systems’ 
equilibration. This parameter was determined by dividing the area of the xy plane, 
which covers the lipid’s nitrogen atoms, by the total number of lipids in one layer (36 for 
caffeine membrane system, and 100 for nelfinavir and atorvastatin membrane sys-
tems). [62] Looking at Table V, in which the area per lipid average value for each 
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membrane system over the last 10 ns of the MD runs is presented, we observe a high 
consistency with experimental data, 0.691/0.674 nm2 (30ºC)[79, 80]. 
 
 
Fig. 20 - Graphical representation of membrane groups’ densities of (A) caffeine, (B) nelfinavir, and (C) 
atorvastatin membrane systems, over the last 10 ns of the MD runs. 
Table V - Bilayer thickness and area per lipid’s values averaged for the last 10 
ns of the MD runs. 
System 
Bilayer thickness /   
nm 
Area per lipid /   
nm2 
Caffeine 3.81 0.6436 
Nelfinavir 3.80 0.6645 
Atorvastatin 3.78 0.6592 
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Fig. 21 - Graphical representation of deuterium order parameters for the sn-1 and sn-2 acyl chains of 
(A) caffeine, (B) nelfinavir, and (C) atorvastatin membrane systems, over the last 10 ns of the MD runs. 
Experimental values extracted from Waschawski et al.[81] 
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4.3   Protocol Adapting 
To perform umbrella sampling calculations on GROMACS, the ‘Umbrella Sampling’ 
tutorial written by Justin Lemkul was followed. However, in this tutorial, Lemkul and his 
co-workers had used the umbrella sampling to calculate the free energy of the dissoci-
ation of a single peptide from the growing end of an Aβ42 protofibril. [82] Therefore, it 
was necessary to adapt the Lemkul’s tutorial to the system that we wanted to study, 
and in this regard, umbrella sampling was primarily performed for caffeine. This was 
due to the smaller size of this compound, which results in faster simulations. 
As stated earlier (see section 2.5), the accuracy of the PMF profile depends largely 
on the width and on the overlap of the sampling windows, and to achieve an accurate 
PMF profile, one has to conduct several simulations while varying the harmonic force 
constant. In Table VI the number of configurations calculated and total simulation time 
for all umbrella sampling simulations performed are shown, though only some of them 
will be discussed.  
Firstly, we conducted an umbrella sampling simulation for the first 25 ξ points with 
a space of 0.2 nm between them, and 6 ns (1 ns of NPT and 5 ns of a production simu-
lation) per ξ, which results in 150 ns on the whole. A harmonic force constant of 500 
kJ•mol-1•nm-2 was used. In Fig. 22 the PMF and the umbrella histograms are repre-
sented, and an exceeding overlap of umbrella windows in some regions is observed, 
which though they do not impart the accuracy of the results, they required more simula-
tions to cover the entire reaction coordinate. We thought at first that by increasing the 
harmonic constant force we would improve the overlap between neighboring windows.  
Harmonic force 
constant / 
kJ•mol-1•nm-2 
Pull geometry No. of	ξ points Time per ξ point / ns 
Simulation’s time / 
ns 
500 position 25 6 150 
800 position 26 6 150 
1000 position 25 6 150 
2000 position 46 6 276 
2000 position 20 21 420 
2000 cylinder 30 6 180 
3000 position 30 6 180 
4000 position 30 6 180 
Table VI - Overview of umbrella sampling simulations performed for method validation. 
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Fig. 22 - PMF profile and umbrella histograms for the validation of the umbrella sampling protocol, 
considering the caffeine membrane system’s simulations. Umbrella sampling was conducted following 
a ‘position’ geometry protocol and a harmonic force constant of 500 kJ•mol-1•nm-2 for 25 configurations 
spaced by 0.2 nm. The free energy in water was set to be zero. 
 
Thus, an equal umbrella sampling simulation, but with a harmonic force constant of 
1000 kJ•mol-1•nm-2, was performed. The results are shown in Fig. 23, where an en-
hanced PMF profile, and a refined and smoother distribution of umbrella histograms 
can be observed. However, not only there are still some regions with an excess over-
lap, but also there were some regions in which there was no overlap. Once again, to 
improve the histogram distribution, a third harmonic force constant of 2000 kJ•mol-
1•nm-2 was tested. In this third situation, more sampling configurations were included to 
overcome the lack of sampling windows in some regions; however, there was still over-
lapped sampling windows, as can be seen in Fig. 24. Although not shown, umbrella 
sampling simulations with harmonic force constants of 800, 3000, and 4000 kJ•mol-
1•nm-2 were performed. 
While we were trying to improve the method, by conducting new simulations vary-
ing the harmonic force constant, and adding more sampling configurations, we were 
faced with different pull geometry protocols on GROMACS that seem to be designed 
specifically for a layered system, as for instance, for a lipid bilayer in order to minimize 
the effects of membrane undulations. While  ‘position’ geometry allows us to calculate 
the PMF of a drug as function of its distance from the whole lipid bilayer, ‘cylinder’ ge-
ometry defines the reaction coordinate more locally not using all the atoms of the refer-
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ence group, but instead dynamically only those within a cylinder around the pull vector 
going through the pull group, see Fig. 25. 
 
Fig. 23 - PMF profile and umbrella histograms for the validation of the umbrella sampling protocol, con-
sidering the caffeine membrane system’s simulations. Umbrella sampling was conducted following a ‘po-
sition’ geometry protocol and a	 harmonic force constant of 1000 kJ•mol-1•nm-2 for 25 configurations 
spaced by 0.2 nm. The free energy in water was set to be zero. 
Fig. 24 - PMF profile and umbrella histograms for the validation of the umbrella sampling protocol, con-
sidering the caffeine membrane system’s simulations. Umbrella sampling was conducted following a ‘po-
sition’ geometry protocol and a	harmonic force constant of 2000 kJ•mol-1•nm-2 for 46 configurations. The 
free energy in water was set to be zero. 
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Fig. 25 - Representation of a ‘cylinder’ geometry’ setting. The z-axis is perpendicular to the bilayer. The 
molecule is confined within a cylinder of radius Rcyl. The z coordinate of the compound’s center of mass, 
relatively to the center of membrane defines the reaction coordinate ξ. Adapted from Gordon et al.[83] 
 
To apply the ‘cylinder’ geometry we had to create a new protocol from scratch, 
since there is no available protocol suitable for our studies. Hence, several umbrella 
sampling calculations, with ‘cylinder’ geometry, varying the harmonic force constants, 
were conducted. Harmonic forces ranging from 500 to 4000 kJ.mol-1.nm-2 were tested, 
and the same problems founded in umbrella sampling with ‘position’ geometry were 
found with the ‘cylinder’ geometry. For several cases, the umbrella histograms pre-
sented a large overlap between some windows or the lack of sampling for other re-
gions of the reaction coordinate, as can be seen in Fig. 26. Moreover, displacements of 
some sampling windows along the reaction coordinate were also detected, that is to 
say, the position in the umbrella histograms in some sampling windows did not corre-
spond to the reference distance at t=0. By carefully analyzing the literature and the 
feedback from forums of the GROMACS simulation package, we detected that there 
could possibly exist an error with the ‘cylinder’ geometry, in which pull group departs 
from its initial position, not getting fixed. Such problem was overcome by defining indi-
vidually the distance (ξ, see Fig. 25) of the pull group to the reference group for each 
sampling configuration, which allowed for an improvement of the distribution of the um-
brella histograms, as can be noted in Fig. 27.A, and the PFM profile shown in Fig. 28. 
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This new protocol was then applied to nelfinavir and atorvastatin membrane sys-
tems, resulting in sampling windows well overlapped in both cases, Fig. 27.B and C. 
The PMF profiles are shown in Fig. 29.A and 11.B and will be discussed, in the subse-
quent chapter, despite not being possible to conclude all sampling windows simulation 
for the nelfinavir membrane system in time for this thesis’ deadline. 
 
4.4   PMF characterization 
The free energy profiles for caffeine, nelfinavir, and atorvastatin are shown in Fig. 28, 
29.A and 29.B, respectively, and the number of configurations calculated for each mol-
ecule and simulation’s time are shown on Table VII. As can be seen from Fig. 28, the 
PMF profile of caffeine shows two minimums with similar values, -0.94 and -0.66 
kcal•mol-1, located at -1.37 nm and 1.36 nm, respectively (corresponding to symmetric 
positions within the bilayer). Energy minimum values represent the most energetically 
favorable positions of the molecule on the bilayer. Both minimums obtained are located 
in the polar head regions of the bilayer, and this is an expected behavior due to the po-
lar character of caffeine. According to data found in literature, our results are consistent 
with that data, since it has been described the minimum energy of caffeine is located at 
the water/lipid interface.[84] The water/lipid barrier, ΔGwat, reflects the affinity of the  
Fig. 26 - PMF profile and umbrella histograms for the validation of the umbrella sampling protocol, 
considering the caffeine membrane system’s simulations. Umbrella sampling was conducted following 
a ‘cylinder’ geometry protocol and a	harmonic force constant of 2000 kJ•mol-1•nm-2. The free energy in 
water was set to be zero 
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Fig. 27 - Umbrella histograms for the validation of the umbrella sampling protocol, considering the (A) caf-
feine, (B) nelfinavir, and (C) atorvastatin membrane system’s simulations. Umbrella sampling simulations 
were conducted following a ‘cylinder’ geometry protocol and a	harmonic force constant of 2000 kJ•mol-1•nm-2. 
 
drug to the bilayer in comparison to the water environment, and according to litera-
ture[84], a gradual decrease in ΔGwat was expected, but an energy peak at -2.11 nm 
(water/membrane interface) is observed instead. However, at the opposite site, at 2.11 
nm (opposite water/membrane interface), no energy peak is detected, which means 
that our PMF profile is not symmetrical as it was supposed. 
The shape of free energy profiles for nelfinavir and atorvastatin are different from 
that for caffeine. Looking at PMF profile for nelfinavir in Fig. 29.A, the energy decreas-
es with nelfinavir coming from bulk water to DOPC membrane until it reaches a mini-
mum (-2.82 kcal•mol-1 at -1.82 nm (polar heads)). Then, the energy starts to increase 
as it approaches the bilayer center, and continues to rise till +0.72 nm (acyl chains), 
declining further to reach a new minimum at 1.33 nm (polar heads/acyl chains inter-
face) (19.25 kcal•mol-1).  
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Fig. 28 - PMF profile of caffeine membrane system’s simulation. Umbrella sampling was conducted follow-
ing a ‘cylinder’ geometry protocol and a	harmonic force constant of 2000 kJ•mol-1•nm-2. Density profiles for 
different membrane groups are also shown. The free energy in water was set to be zero. 
 
Similarly to nelfinavir, in the PMF profile for atorvastatin in Fig. 29.B we can observe 
a slightly decrease in energy as atorvastatin comes from the bulk water to DOPC 
membrane until it reaches a minimum (-0.77 kcal•mol-1at -1.62 nm (polar heads)). 
Then, the energy also starts to increase as it approaches the bilayer center, and con-
tinues to rise till the +0.85 nm (acyl chains) position. 
Nevertheless, a decrease in the free energy after the membrane center for nelfinavir 
and atorvastatin was expected. The continuous increase in energy after the mem-
branes’ center might be due to several factors. A trajectory analysis of the nelfinavir 
Table VII - Number of configurations and total simulations’ time, taking into account 6 ns per 
configuration. 
Molecule No. of	ξ points Simulation’s time / ns 
Caffeine 56 336 
Atorvastatin 50 300 
Nelfinavir 51 306 
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umbrella sampling simulation revealed the drug assumes the same orientation along 
the reaction coordinate: when nelfinavir enters the membrane, the more apolar groups 
are facing the acyl chains, whereas when it is coming out of the other side of the mem-
brane the same groups are facing the water. This can naturally result in a less stable 
orientation, which can lead to an increase in free energy; however, we must under-
stand whether this effect is real or a misleading result. In addition, nelfinavir is a bulky 
molecule and due to the membrane’s viscosity it tends to move more difficulty and 
more slowly inside the membrane. Thus, a simulation time of 5 ns per configuration 
seems to be not enough so nelfinavir can explore all conformations, and we must in-
crease the simulation time. In the case of atorvastatin, when its trajectory was ana-
lyzed, we noted the orientation of atorvastatin changes along the reaction coordinate. 
However, because atorvastatin has a higher MW and it might be stiffer than nelfinavir, 
it becomes even tougher to move around the membrane. Once again, we must in-
crease the simulations time in order to improve the free energy profiles. 
Drug’s permeability depends largely on the bilayer center penetration barrier, ΔGpen, 
which is related to the velocity of transfer of the molecule to the other monolayer (bi-
layer leaflet), and is calculated by the difference between the minimal free energy and 
the maximal free energy. The values of ΔGpen for caffeine, nelfinavir, and atorvastatin, 
as well as the experimental permeability values are shown in Table VIII, where an in-
verse correlation between ΔGpen and permeability can be observed. Caffeine, which is 
the most permeable compound from the three tested, has the lowest ΔGpen, whereas 
nelfinavir, which is the less permeable, has the highest ΔGpen. Despite the non-perfect 
profiles that we obtained for these compounds we could still correlate the ΔGpen with 
the compounds’ permeability. Seeing that one of the main goals of this work is estab-
lish the molecular properties that are essential for the passive diffusion of compounds 
through cell membranes, or even predict new ones, these are very promising results 
that could change the way molecular diffusion is characterized. Obviously, the protocol 
needs to be extensively validated and refined for us to achieve such promise.   
Molecule ∆G
wat / 
 kcal•mol-1 
∆Gpen / 
kcal•mol-1 
 Permeability a / 
cm•s-1 
Caffeine 0.94 / 1.60 6.18 
 
50.5 x10-6 
Atorvastatin 0.77 22.31 
 
4.9 x10-6 
Nelfinavir 2.82 25.80 
 
1.39 x10-6 
Table VIII - The calculated water/lipid barrier, bilayer center penetration barrier, and experi-
mental permeability. 
a high permeability ≥ 10 x10-6 cm•s-1; 2.5 x10-6 ≤ moderate permeability < 10 x10-6 cm•s-1; 
low permeability < 2.5 x10-6 cm•s-1 
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Fig. 29 - PMF profile of (A) nelfinavir and (B) atorvastatin membrane system’s simulations. Umbrella sampling 
was conducted following a ‘cylinder’ geometry protocol and a	harmonic force constant of 2000 kJ•mol-1•nm-2. 
Density profiles for each membrane are also shown. The free energy in water was set to be zero.  
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4.5   Rotatable bonds and PSA characterization 
Nelfinavir and atorvastatin have 10 and 12 rotatable bonds, respectively, and for both 
molecules the rotatable bonds are shown in Fig30. From the figure it may be possible 
to predict if nelfinavir is more flexible than atorvastatin; as can be seen, nelfinavir has a 
carbon atom that makes part of 3 rotatable bonds (see Fig. 30.A), which mean that this 
atom is a kind of ‘rotatable center’. A visual analysis of nelfinavir simulation allows us to 
observe not only a different molecular groups orientation over time as was expected, 
but also a change in its shape, as in can be seen in Fig. 31. Therefore, we asked our-
Fig. 30 - Nelfinavir  (A) and Atorvastatin’s (B) chemical representations with the rotatable bonds 
highlighted in red and the polar surface area depicted as the incomplete spheres surrounding 
the colored hetero-atoms: nitrogen (blue), oxygen (red)(and any hydrogen atom attached to 
these atoms), and sulfur (yellow). The vertical arrow is pointing the ‘rotatable center’ and the 
horizontal one is pointing the most relevant rotatable bond for nelfinavir’s conformation (see text 
for more details). 
A 
 
B 
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selves whether the changes in nelfinavir shape could result in PSA changes. In order 
do answer this question, first we calculated the average value for PSA from a simula-
tion of nelfinavir inside a water box; secondly, we have verified the most relevant rotat-
able bonds for shape flickers; and thirdly, we run simulations with those rotatable 
bonds constricted to evaluate the PSA. 
The rotatable bond pointed out in Fig. 30.A was the one that showed a greater rele-
vance for nelfinavir’s conformation. As can be seen in Fig. 32, the dihedral angle can 
be at  -70°, +55º, or even at +180º. Thus, three simulations, in which this rotatable 
bond was constrained at each of those angle values, were performed. The resulting 
PSA values calculated from each simulation, as well as the value calculated for the 
free simulation in water, are shown in Table IX. As it can be observed, the difference 
between the PSA values in each case is negligible, which means that a relation be-
tween the dihedral angle and PSA cannot be deduced for now. As a matter of fact, this 
was a preliminary study, and other studies will be needed. Nonetheless, the PSA value 
obtained for nelfinavir is somehow concordant with the value found in literature. 
Fig. 31 - Ball-and-Stick visualization of Nelfinavir 
with the most relevant rotatable bond for its con-
formation set at +55º (A), -70º (B), and 180º (C). 
A 
C 
B 
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Relatively to atorvastatin, due to a matter of time, it was only calculated its PSA val-
ue, yielding 110.68 Å2, which is similar to the value found in the literature (see Table I 
in section 3.3). 
In order to try to understand Veber’s rules: why rigidity facilitates the diffusion pro-
cess, and how rotatable bonds influence the molecular flexibility; as well as how rotat-
able bonds also influence the PSA, umbrella sampling simulations in a membrane sys-
tem, in which rotatable bonds are constrained, will be performed prospectively. 
 
Fig. 32 - Dihedral angle distribution of the most relevant rotatable bond for 
Nelfinavir’s conformation (see text for more details).  
Constraint / 
Degrees (º) 
 Polar Surface Area /  
Å2 
No constraint 
 
105.40 
+55 
 
99.16 
-70 
 
108.00 
+180 
 
96.17 
Table IX - PSA values obtained for nelfinavir. 
-150 -100 -50 0 50 100 150
Degrees (º)
0
0.002
0.004
0.006
0.008
0.01
0.012
0.014
0.016
60 FCUP/ICBAS 
Development of a computational protocol to study passive diffusion through biological membranes 
 
 
  
FCUP/ICBAS 
Development of a computational protocol to study passive diffusion through biological membranes 
61 
 
 
 
 
 
 
 
CHAPTER 5 
 
Conclusions 
 
In this thesis umbrella sampling simulations have been used to study the fundamental 
processes that occur during passive diffusion of drugs through biological membranes.  
We began our study by selecting a small library of compounds, whose free energies 
in water and in 1-octanol were calculated in order to validate the force field that was 
being used. Regarding free energy calculations in water, we obtained an acceptable 
error of 1.15 kcal•mol-1, on average, between our computationally determined values 
and the experimental ones, which supports the accuracy of the force field that was be-
ing used in describing hydration free energies for this subset of compounds. Concern-
ing free energies calculations in 1-octanol, a discrepancy of 2.33 kcal•mol-1 between 
the theoretical and experimental ΔGsolv values was observed, which is an indicator of 
the force field’s accuracy limits. To improve this result, we should working on 1-octanol 
parameters refinement. Nevertheless, such error cannot impart the results obtained for 
membrane studies, since DOPC’s parameters have been extensively validated. 
In a second stage of the work, we built a DOPC/water membrane model, in which a 
molecule of caffeine was included, and we started to optimize the umbrella sampling 
protocols. To do that, we tested a series of important settings: simulation time, harmon-
ic force constant, pull geometry, and pull rate. From all pull geometries in GROMACS, 
only two of them were used: position and cylinder. In the end, the cylinder geometry 
has revealed itself as the best pull geometry option for these systems; not only it was 
specifically designed for layered systems, allowing for the minimization of membrane 
undulation effects, but also it yielded the best sampling results. The resulting PMF for 
caffeine, with the cylinder geometry was very similar to the one found in literature. 
In the next stage, umbrella sampling simulations for nelfinavir and atorvastatin were 
performed. Although the obtained PMF profiles had shown that we must increase the 
simulation time, since a simulation time of 5 ns per configuration seemed to be not 
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enough so nelfinavir could explore all conformations, we could still observe an inverse 
correlation between the ΔGpen with permeability: caffeine, which is the most permeable 
compound from the three tested, has the lowest ΔGpen, whereas nelfinavir, which is the 
less permeable, has the highest ΔGpen. Consequently, these promising results may be 
a turning point in the way molecular diffusion is characterized. However, extensive 
studies will be needed to achieve such promise. 
Lastly, nelfinavir and atorvastatin’s rotatable bonds and PSA were characterized. 
We observed that although nelfinavir has less two rotatable bonds than atorvastatin, it 
has a ‘rotatable center’, that is to say, it has a carbon atom that makes part of 3 rotata-
ble bonds, which probably makes it more flexible than atorvastatin. Seeing that mo-
lecular flexibility hinds the passive diffusion, such observation indicates nelfinavir has a 
bad permeability, which is confirmed by experimental data. As a result, molecular flexi-
bility can be no longer defined exclusively by the quantity of rotatable bonds, but also 
by its distribution in the molecule. However, some interesting questions arose: 1) why 
molecular flexibility hinds passive diffusion; 2) whether stiffness is important at any part 
of the molecule; 3) how many conformational states does the molecule have in solu-
tion; 4) how PSA changes with the rotatable bonds count and rotatable bounds distri-
bution. 
To answer this question, we propose, in the future, to constrain rotatable bonds to 
decrease the flexibility, and perform umbrella sampling calculations. We also propose a 
previous rotatable bonds’ characterization in the water/lipid interface and in the core of 
the membrane, in order to see in which values rotatable bonds should be constrained.  
To conclude, in this work, we developed a new protocol to study the molecular 
properties required for drugs’ passive diffusion, which can be subsequently applied to a 
large number of molecules. 
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